Codiak BioSciences, Inc. Depreciation
Codiak BioSciences, Inc. reported Depreciation of $4.36 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2021-03-17
- Codiak BioSciences, Inc. depreciation for the quarter ending 2020-12-31 was $1.28M, a 33.92% increase year-over-year.
- Codiak BioSciences, Inc. depreciation for the quarter ending 2019-12-31 was $958.00K.
- Codiak BioSciences, Inc. depreciation for fiscal 2020 was $4.36M, a 57.40% increase from fiscal 2019.
- Codiak BioSciences, Inc. depreciation for fiscal 2019 was $2.77M.
| Period end | Depreciation 3 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $4.36M 10-K · filed 2021-03-17 | |
| 2020-09-30 | $3.08M 10-Q · filed 2020-11-19 | ||
| 2019-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $2.77M 10-K · filed 2021-03-17 | |
| 2019-09-30 | $1.81M 10-Q · filed 2020-11-19 |